Other Clinical Trial - Peri-operative Expression Analysis of Pancreatic

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT05980910` - Protective and Risk Factors for QoR-15 for Major Abdominal Surgery
	Completed	`NCT01627873` - Effect of Remifentanil on Postoperative Cognition Function in Patients Undergoing Major Abdominal Surgery	Phase 4

See also

Status

Clinical Trial

Phase

Recruiting

NCT05980910 - Protective and Risk Factors for QoR-15 for Major Abdominal Surgery

Completed

NCT01627873 - Effect of Remifentanil on Postoperative Cognition Function in Patients Undergoing Major Abdominal Surgery

Phase 4

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01258179
Study type	Observational
Source	University of Zurich
Contact
Status	Terminated
Phase
Start date	February 2011
Completion date	December 2017

Peri-operative Expression Analysis of Pancreatic Stone Protein in a Surgical Study Population

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms